Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Pagani

Showing results (161-170 of 172) with videos related to

Pageof 18
Sort By:
Haematologica|July 7, 2018
<i>BCR-ABL1</i> genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemiaIlaria S Pagani, Phuong Dang, Ivar O Kommers, et al.
Blood|September 2, 2020
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemiaNaranie Shanmuganathan, Ilaria S Pagani, David M Ross, et al.
British Journal of Haematology|March 28, 2019
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemiaDavid M Ross, Ilaria S Pagani, Yazad D Irani, et al.
Oncogene|April 12, 2011
OTX1 expression in breast cancer is regulated by p53A Terrinoni, I S Pagani, I Zucchi, et al.
Blood|August 24, 2023
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapyIlaria S Pagani, Naranie Shanmuganathan, Phuong Dang, et al.
Oncoscience|January 17, 2015
Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid LeukemiaIlaria S Pagani, Orietta Spinelli, Elia Mattarucchi, et al.
Leukemia|November 27, 2019
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionIlaria S Pagani, Phuong Dang, Verity A Saunders, et al.
The Breast Journal|November 6, 2010
The mammary gland and the homeobox gene Otx1Ilaria S Pagani, Alessandro Terrinoni, Laura Marenghi, et al.
Leukemia|October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsDavid M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Haematologica|March 23, 2023
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment interventionNaranie Shanmuganathan, Carol Wadham, NurHezrin Shahrin, et al.
Pageof 18

Showing results (161-170 of 172) with videos related to

Sort By:
Pageof 18
Haematologica|July 7, 2018
<i>BCR-ABL1</i> genomic DNA PCR response kinetics during first-line imatinib treatment of chronic myeloid leukemiaIlaria S Pagani, Phuong Dang, Ivar O Kommers, et al.
Blood|September 2, 2020
Early BCR-ABL1 kinetics are predictive of subsequent achievement of treatment-free remission in chronic myeloid leukemiaNaranie Shanmuganathan, Ilaria S Pagani, David M Ross, et al.
British Journal of Haematology|March 28, 2019
Lenalidomide maintenance treatment after imatinib discontinuation: results of a phase 1 clinical trial in chronic myeloid leukaemiaDavid M Ross, Ilaria S Pagani, Yazad D Irani, et al.
Oncogene|April 12, 2011
OTX1 expression in breast cancer is regulated by p53A Terrinoni, I S Pagani, I Zucchi, et al.
Blood|August 24, 2023
Lineage-specific detection of residual disease predicts relapse in patients with chronic myeloid leukemia stopping therapyIlaria S Pagani, Naranie Shanmuganathan, Phuong Dang, et al.
Oncoscience|January 17, 2015
Genomic quantitative real-time PCR proves residual disease positivity in more than 30% samples with negative mRNA-based qRT-PCR in Chronic Myeloid LeukemiaIlaria S Pagani, Orietta Spinelli, Elia Mattarucchi, et al.
Leukemia|November 27, 2019
Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remissionIlaria S Pagani, Phuong Dang, Verity A Saunders, et al.
The Breast Journal|November 6, 2010
The mammary gland and the homeobox gene Otx1Ilaria S Pagani, Alessandro Terrinoni, Laura Marenghi, et al.
Leukemia|October 14, 2018
Long-term treatment-free remission of chronic myeloid leukemia with falling levels of residual leukemic cellsDavid M Ross, Ilaria S Pagani, Naranie Shanmuganathan, et al.
Haematologica|March 23, 2023
Impact of additional genetic abnormalities at diagnosis of chronic myeloid leukemia for first-line imatinib-treated patients receiving proactive treatment interventionNaranie Shanmuganathan, Carol Wadham, NurHezrin Shahrin, et al.
Pageof 18